ICUI · Icu Medical Inc · Exempt Offerings
One customer — 20% of revenue (three months ended September 30, 2026)
“For the three and nine months ended September 30, 2026, our consolidated worldwide net sales to a single distributor were 20%, and 19%, respectively, and for the three and nine months ended September 30, 2025, were 17% and 17%.”
One customer — 19% of revenue (nine months ended September 30, 2026)
“For the three and nine months ended September 30, 2026, our consolidated worldwide net sales to a single distributor were 20%, and 19%, respectively, and for the three and nine months ended September 30, 2025, were 17% and 17%.”
One customer — 17% of revenue (nine months ended September 30, 2025)
“For the three and nine months ended September 30, 2026, our consolidated worldwide net sales to a single distributor were 20%, and 19%, respectively, and for the three and nine months ended September 30, 2025, were 17% and 17%.”
One customer — 17% of revenue (three months ended September 30, 2025)
“For the three and nine months ended September 30, 2026, our consolidated worldwide net sales to a single distributor were 20%, and 19%, respectively, and for the three and nine months ended September 30, 2025, were 17% and 17%.”
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
No Exempt Offerings
No Form D exempt-offering notices are available for this stock yet.